A further study of the cytotoxic constituents of a milnamide-producing sponge

A reinvestigation of Auletta sp. yielded the novel compound milnamide C (3) plus the known compounds milnamide A (1), milnamide B (hemiasterlin) (2), jasplakinolide (5), and geodiamolides A (6), D (7), E (8), and G (9). The isolation work was guided by cytoskeletal bioactivity data. Compounds 2 and 3 were shown to cause microtubule depolymerization, and 6-9 were shown to cause microfilament disruption. This biological activity and the structural elucidation of 3, including X-ray analysis, are reported here. [structure: see text]     

Low-coordinate chromium siloxides: the "box" [Cr(mu-Cl)(mu-OSitBu3)]4, distorted trigonal [(tBu3SiO)3Cr][Na(benzene)] and [(tBu3SiO)3Cr][Na(dibenzo-18-c-6)], and trigonal (tBu3SiO)3Cr

Treatment of CrCl(2)(THF)(2) with NaOSi(t)Bu(3) afforded the tetrameric "box" [Cr(mu-Cl)(mu-OSi(t)Bu(3))](4) (1, X-ray). THF cleaved 1 to provide trans-(silox)ClCr(THF)(2) (2), whereas degradation of 1 with 4-picoline caused disproportionation and the generation of trans-Cl(2)Cr(4-pic)(2) and trans-(silox)(2)Cr(4-pic)(x) (n = 2, 3; 3, 3-4-pic). Chromous centers in 1 were antiferromagnetically coupled, and density functional calculations on the high-spin (multiplicity = 17) model [Cr(mu-Cl)(mu-OH)](4) (1') revealed that its singly occupied 3d orbitals spanned an energy range of approximately 2 eV. The addition of 8 equiv of Na(silox) to 1 yielded [((t)Bu(3)SiO)Cr(mu-OSi(t)Bu(3))(2)]Na.C(6)H(6) (4, Y shaped, angle OCrO(Na) = 91.28(7) degrees), and treatment of 4 with dibenzo-18-crown-6 produced [(silox)(3)Cr][Na(dibenzo-18-crown-6)] (5, angle OCrO = approximately 120 degrees, (120 + alpha) degrees, (120 - alpha) degrees). Calculations of [((t)Bu(3)SiO)Cr(mu-OSi(t)Bu(3))(2)]Na (4') and Cr(silox)(3)(-) (5') provided reasonable matches with the experimental geometries (X-ray). The trigonal chromic derivative (silox)(3)Cr (6) was synthesized from CrCl(3)(THF)(3) for structural and calculational comparisons to the chromous derivatives.     

Bis(imino)pyridine iron(II) alkyl cations for olefin polymerization

Treatment of the five-coordinate ferrous dialkyl complex, (iPrPDI)Fe(CH2SiMe3)2 (iPrPDI = ((2,6-CHMe2)2C6H3N=CMe)2C5H3N), with [PhMe2NH][BPh4] in the presence of diethyl ether or tetrahydrofuran furnished the corresponding alkyl cations, where the donor ligand is coordinated in the basal plane of a distorted square pyramidal iron(II) alkyl cation. Performing the same reaction with the neutral Lewis acid, B(C6F5)3, induced methide abstraction from a silicon atom followed by rearrangement to afford the base free ferrous alkyl cation, [(iPrPDI)Fe(CH2SiMe2CH2SiMe3)][MeB(C6F5)3]. This complex is active for the polymerization of ethylene and yields polymers that are of higher molecular weight and narrower polydispersity than traditional methylalumoxane-activated catalysts.     

Cyclopentadienyl substituent effects on reductive elimination reactions in group 4 metallocenes: kinetics,mechanism, and application to dinitrogen activation

The rate of reductive elimination for a family of zirconocene isobutyl hydride complexes, Cp(CpR(n)())Zr(CH(2)CHMe(2))H (Cp = eta(5)-C(5)Me(5), CpR(n)() = substituted cyclopentadienyl), has been measured as a function of cyclopentadienyl substituent. In general, the rate of reductive elimination increases modestly with the incorporation of sterically demanding substituents such as [CMe(3)] or [SiMe(3)]. A series of isotopic labeling experiments was used to elucidate the mechanism and rate-determining step for the reductive elimination process. From these studies, a new zirconocene isobutyl hydride complex, Cp' '(2)Zr(CH(2)CHMe(2))(H) (Cp' ' = eta(5)-C(5)H(3)-1,3-(SiMe(3))(2)), was designed and synthesized such that facile reductive elimination of isobutane and activation of dinitrogen was observed. The resulting dinitrogen complex, [Cp' '(2)Zr](2)(mu(2), eta(2),eta(2)-N(2)), has been characterized by X-ray diffraction and displays a bond length of 1.47 A for the N(2) ligand, the longest observed in any metallocene dinitrogen complex. Solution magnetic susceptibility demonstrates that [Cp' '(2)Zr](2)(mu(2), eta(2), eta(2)-N(2)) is a ground-state triplet, consistent with two Zr(III), d(1) centers. Mechanistic studies reveal that the dinitrogen complex is derived from the reaction of N(2) with the resulting cyclometalated zirconocene hydride rather than directly from reductive elimination of alkane.     

Cryptocin, a potent tetramic acid antimycotic from the endophytic fungus Cryptosporiopsis cf. quercina

[formula: see text] The endophytic fungus Cryptosporiopsis cf. quercina produces cryptocin in culture. Among other fungi, this unique tetramic acid displays antimycotic activity against Pyricularia oryzae, the causal agent of rice blast disease. Cryptocin also possesses activity against a wide variety of plant pathogenic but not human pathogenic fungi. The fine rhomboid-like crystals of cryptocin allowed structural elucidation by X-ray crystallography. The importance of cryptocin to the symbiotic relationship of C. quercina to its hosts is briefly discussed.     

Synthesis of ((t)Bu3SiNH)2ClW triple bond WCl(NHSi(t)Bu3)2 and its degradation via NH bond activation.

Treatment of NaW2Cl7(THF)5 with 4 equiv of (t)Bu3SiNHLi afforded the C2 W(III) dimer [((t)Bu3SiNH)2WCl]2 (1, d(W triple bond W) = 2.337(2) A), which is a rare, primary amide M2X4Y2 species. Its degradation provided evidence of NH bond activation by the ditungsten bond. Addition of 2 equiv of (t)Bu3SiNHLi or TlOSi(t)Bu3 to 1 yielded H2 and hydride ((t)Bu3SiN)2((t)Bu3SiNH)WH (2, d(WH) = 1.67(3) A) or ((t)Bu3SiN)2((t)Bu3SiO)WH (3). Thermolysis (60 degrees C, 16 h) of 1 in py gave ((t)Bu3SiN)2WHCl(py) (4-py, 40-50%), ((t)Bu3SiN)2WCl2(py) (6-py, 10%), and ((t)Bu3SiN)2HW(mu-Cl)(mu-H)2W(NSi(t)Bu3)py2 (5-py2, 5%), whereas thermolysis in DME produced ((t)Bu3SiN)2WCl(OMe) (7, 30%), ((t)Bu3SiN)2WCl2 (6, 20%), and ((t)Bu3SiN)2HW(mu-Cl)(mu-H)2W(NSi(t)Bu3)DME (5-DME, 3%). Compound 7 was independently produced via thermolysis of 4-py and DME (-MeOEt, -py), and THF and ethylene oxide addition to hydride 2 gave ((t)Bu3SiN)2((t)Bu3SiNH)WO(n)Bu (8) and ((t)Bu3SiN)2((t)Bu3SiNH)WOEt (9), respectively. Dichloride 6 was isolated from SnCl4 treatment of 1 with the loss of H2. Sequential NH bond activations by the W2 core lead to "((t)Bu3SiN)2WHCl" (4) and subsequent thermal degradation products. Thermolysis of 1 in the presence of H2C=CH(t)Bu and PhC triple bond CPh trapped 4 and generated ((t)Bu3SiN)2W((neo)Hex)Cl (10) and a approximately 6:1 mixture of ((t)Bu3SiN)2WCl(cis-CPh=CPhH) (11-cis) and ((t)Bu(3)SiN)2WCl(trans-CPh=CPhH) (11-trans), respectively. Thermolysis of the latter mixture afforded ((t)Bu3SiNH)((t)Bu3SiN)WCl(eta2-PhCCPh) (12) as the major constituent. Alkylation of 1 with MeMgBr produced ((t)Bu3SiN)2W(CH3)2 (13), as did addition of 2 equiv of MeMgBr to 6. X-ray crystal structure determinations of 1, 2, 5-py2, 6-py, 11-trans, and 12 confirmed spectroscopic identifications. A general mechanism that features a sequence of NH activations to generate 4, followed by chloride metathesis, olefin insertion, etc., explains the formation of all products.     

Structures and cytotoxic properties of sponge-derived bisannulated acridines

A reinvestigation of sponge natural products from additional Indo-Pacific collections of Xestospongiacf. carbonaria and X. cf. exigua has provided further insights on the structures, biological activities, and biosynthetic origin of bisannulated acridines. These alkaloids include one known pyridoacridine, neoamphimedine (2), and three new analogues, 5-methoxyneoamphimedine (4), neoamphimedine Y (5), and neoamphimedine Z (6). A completely new acridine, alpkinidine (7), was also isolated. A disk diffusion soft agar assay, using a panel of five cancer cell lines (solid tumors and leukemias) and two normal cells, was used to evaluate the differential cytotoxicity (solid tumor selectivity) of the sponge semipure extracts and selected compounds including amphimedine (1), 2, 4, and 7. While all four compounds were solid tumor selective, 1 and 2 were the most potent and 4 was the most selective. The rationale used to characterize the new structures is outlined along with the related biosynthetic pathways envisioned to generate 2 and 7.     

Kinetics and mechanism of N2 hydrogenation in bis(cyclopentadienyl) zirconium complexes and dinitrogen functionalization by 1,2-addition of a saturated C-H bond

The rates of hydrogenation of the N2 ligand in the side-on bound dinitrogen compounds, [(eta(5)-C5Me4H)2Zr]2(mu2,eta(2),eta(2)-N2) and [(eta(5)-C5Me5)(eta(5)-C5H2-1,2-Me2-4-R)Zr]2(mu2,eta(2),eta(2)-N2) (R = Me, Ph), to afford the corresponding hydrido zirconocene diazenido complexes have been measured by electronic spectroscopy. Determination of the rate law for the hydrogenation of [(eta(5)-C5Me5)(eta(5)-C5H2-1,2,4-Me3)Zr]2(mu2,eta(2),eta(2)-N2) establishes an overall second-order reaction, first order with respect to each reagent. These data, in combination with a normal, primary kinetic isotope effect of 2.2(1) for H2 versus D2 addition, establish the first H2 addition as the rate-determining step in N2 hydrogenation. Kinetic isotope effects of similar direction and magnitude have also been measured for hydrogenation (deuteration) of the two other zirconocene dinitrogen complexes. Measuring the rate constants for the hydrogenation of [(eta(5)-C5Me5)(eta(5)-C5H2-1,2,4-Me3)Zr]2(mu2,eta(2),eta(2)-N2) over a 40 degrees C temperature range provided activation parameters of deltaH(double dagger) = 8.4(8) kcal/mol and deltaS(double dagger) = -33(4) eu. The entropy of activation is consistent with an ordered four-centered transition structure, where H2 undergoes formal 1,2-addition to a zirconium-nitrogen bond with considerable multiple bond character. Support for this hypothesis stems from the observation of N2 functionalization by C-H activation of a cyclopentadienyl methyl substituent in the mixed ring dinitrogen complexes, [(eta(5)-C5Me5)(eta(5)-C5H2-1,2-Me2-4-R)Zr]2(mu2,eta(2),eta(2)-N2) (R = Me, Ph), to afford cyclometalated zirconocene diazenido derivatives.     

Refinement of the crystal structure of (RS)-carnitine hydrochloride

A single crystal of (RS)-carnitine hydrochloride has been obtained, and its crystal structure has been refined by an x-ray structural experiment.Tashkent Pharmaceutical Institute. Translated from Khimiya Prirodnykh Soedinenii, No. 6, pp. 842–844, November–December, 1991.